This post was originally published on this site
The healthcare industry has been one of the major beneficiaries of market optimism over the past few months. Companies in this space have invested heavily in research and development to strengthen their positions in the market. According to LBMC’s fourth annual Business Outlook Survey Report, 92% of healthcare organizations expect substantial revenue growth in 2021.
Given the rising demand for healthcare services worldwide and robust tech integration in the industry, we think betting on large-cap stocks Abbott Laboratories (ABT), Thermo Fisher Scientific Inc. (NYSE:TMO), and Medtronic plc (MDT), which possess solid growth attributes, could be rewarding.
